当前位置：首页 > 文献互助 > 互助详情

Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials复制

飞天小兔神 1个月前 83 10 已完结

1. 系统已在2026-06-09 14:42:47对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1093/ndt/gfag081复制

文献链接: https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfag081/8661867复制

其他信息:

出版社: Oxford University Press (OUP)
作者: Maaike Mepschen; Remon Vos; William Herrington; Michele Provenzano; Jelle M Beernink; Gaetano La Manna; Ron T Gansevoort; Hiddo J L Heerspink
全文下载地址: https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfag081/68153897/gfag081.pdf

上一篇：Mullite-cellulose synergistically construct advanced composite separators for sodium-ion batteries

下一篇：E-Dakin reaction: oxidation of hydroxybenzaldehydes to phenols with electrochemically generated peroxodicarbonate as sustainable ex-cell oxidizer

互助时间线

2026-06-07 09:51:10 [完结求助]

系统完结了求助, 已自动确认了用户sO6aWzi4HcAU应助的文件是正确的, 求助状态变成 已完结

2026-06-02 14:42:47 [上传文件]

用户sO6aWzi4HcAU上传了文件(pdf 942.07 KB), 求助状态变成 待确认

2026-06-02 09:51:10 [发起求助]

最新发布的求助

Long-term safety and efficacy of intracortical microstimulation in humans 5分钟前
等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 22分钟前
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 34分钟前
Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 39分钟前
Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 40分钟前
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 49分钟前
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 55分钟前
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 57分钟前
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 1小时前
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer 1小时前
Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction … 1小时前
Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com